Polymorphisms of KIR gene and HLA-C alleles: Possible association with susceptibility to HLA-B27-positive patients with ankylosing spondylitis

Journal of Clinical Immunology

Volumn 30, Issue 6, 2010, Pages 840-844

  Jiao, Yu Lian ^a   Zhang, Bing Chang ^a   You, Li ^a   Li, Jian Feng ^a   Zhang, Jie ^a   Ma, Chun Yan ^a   Cui, Bin ^a   Wang, Lai Cheng ^a   Chen, Zi Jiang ^a   Zhao, Yue Ran ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Genotyping; Human leukocyte antigen; Immunoglobulin like receptors; Spondylitis ankylosing

Indexed keywords

HLA B27 ANTIGEN; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL5;

AGED; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-B27 ANTIGEN; HLA-C ANTIGENS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, KIR; SPONDYLITIS, ANKYLOSING;

EID: 78651289009     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-010-9444-z     Document Type: Article

References (24)

1. Marcilla M, López de Castro JA. Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens. 2008;71(6):495-506.
2. Brown MA. Breakthroughs in genetic studies of ankylosing spondylitis. Rheumatology (Oxford). 2008;47(2):132-7.
3. Laurie M, Savage I, editor. The TASC genetic study uncovers two new genes implicated in ankylosing spondylitis. www.spondylitis.org. 2007;4-5.
4. Shamji MF, Bafaquh M, Tsai E. The pathogenesis of ankylosing spondylitis. Neurosurg Focus. 2008;24(1):1-10.
5. Sims AM, Wordsworth BP, Brown MA. Genetic susceptibility to ankylosing spondylitis. Curr Mol Med. 2004;4:13-20.
6. Reveille JD, Ball EJ, Khan MA. HLA-B27 and genetic predisposing factors in spondyloarthropathies. Curr Opin Rheumatol. 2001;13:265-72.
7. Jiao YL, Ma CY, Wang LC, Cui B, Zhang J, You L, et al. Polymorphisms of KIRs gene and HLA-C alleles in patients with ankylosing spondylitis: possible association with susceptibility to the disease. J Clin Immunol. 2008;28:343-9.
8. Moretta A, Bottino C, Vitale M, et al. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol. 2001;19:197-223.
9. Jie HB, Sarvetnick N. The role of NK cells and NK cell receptors in autoimmune disease. Autoimmunity. 2004;37(2):147-53.
10. Maxwell LD, Ross OA, Curran MD, Rea IM, Middleton D. Investigation of KIR diversity in immunosenescence and longevity within the Irish population. Exp Gerontol. 2004;39(8):1223-32.
11. Moretta A, Vitale M, Bottino C, Orengo AM, Morelli L, Augugliaro R, et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells: anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J Exp Med. 1993;178:597-604.
12. Colonna M, Borsellino G, Falco M, Ferrara GB, Strominger JL. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1-and NK2-specific natural killer cells. Proc Natl Acad Sci. 1993;90:12000-4.
13. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity. 1995;3:801-9.
14. Martin MP, Nelson G, Lee JH, et al. Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J Immunol. 2002;169:2818.
15. van der Slik AR, Koeleman BP, Verduijn W, Bruining GJ, Roep BO, Giphart MJ. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes. 2003;52:2639-42.
16. Wang S, Zhao YR, Jiao YL, Wang LC, Li JF, Bin C, et al. Increased activating killer immunoglobulin-like receptor genes and decreased specific HLA-C alleles in couples with recurrent spontaneous abortion. Biochem Biophys Res Commun. 2007;360:696-701.
17. Brown MA, Kennedy LG, Darke C, Gibson K, Pile KD, Shatford JL, et al. The effect of HLA-DR genes on susceptibility to and severity of ankylosing spondylitis. Arthritis Rheum. 1998;41:460-5.
18. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361-8.
19. Single RM, Martin MP, Meyer D, Gao XJ, Carrington M. Methods for assessing gene content diversity of KIR with examples from a global set of populations. Immunogenetics. 2008;60:711-25.
20. van Bergen J, Thompson A, vander Slik A, Ottenhoff TH, Gussekloo J, Koning F. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J Immunol. 2004;173:6719-26.
21. Nakajima T, Goek O, Zhang X, Kopecky SL, Goronzy JJ, Weyand CM. De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes. Circ Res. 2003;93:106-13.
22. Namekawa T, Snyder MR, Yen JH, Goehring BE, Leibson PJ, Weyand CM, et al. Killer cell activating receptors function as costimulatory molecules on CD4 CD28 null T cells clonally expanded in rheumatoid arthritis. J Immunol. 2000;165:1138-45.
23. Fourmentraux-Neves E, Jalil A, Rocha SD, Pichon C, Chouaib S, Bismuth G, et al. Two opposite signaling outputs are driven by the KIR2DL1 receptor in human CD4+ T cells. Blood. 2008;112:2381-9.
24. Alvarez I, Sesma L, Marcilla M, Ramos M, Marti M, Camafeita E, et al. Identification of novel HLA-B27 ligands derived from polymorphic regions of its own or other class I molecules based on direct generation by 20S proteasome. J Biol Chem. 2001;276:32729-37.